Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

  • This share is currently suspended. It was suspended at a price of 725.00
  • There is currently no data for AQX

Block listing application

24 Jun 2025 12:34

RNS Number : 2082O
Aquis Exchange PLC
24 June 2025
 

24 June 2025

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

Block listing application

 

Aquis Exchange PLC (AQX.L), a creator and facilitator of next-generation financial markets, announces that an application has been made to the London Stock Exchange and the Aquis Growth Market for a block listing of securities in respect of a total of 3,000,000 ordinary shares of 10p each (the "New Ordinary Shares").

The block listing application relates to New Ordinary Shares to be issued from time to time to satisfy option exercises and the vesting of share awards in respect of the Aquis Exchange CSOP, the Aquis Exchange Executive Share Option Plan, the Aquis Exchange Omnibus Plan and the Aquis Exchange PLC Enterprise Management Incentive Share Option Plan.

When issued, the New Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of ten pence each in the capital of Aquis.

It is expected that admission will become effective on 27 June 2025

 

Enquiries:

Aquis Exchange PLC

Tel: +44 (0)20 3597 6321

David Stevens, CEO

 

Investec Bank plc (Nominated Adviser and Broker)

Tel: +44 (0)20 7597 5970

David Anderson

St John Hunter

 

Canaccord Genuity Limited (Joint Broker)

Emma Gabriel

George Grainger 

 

 

 

 

Tel: +44 (0) 20 7523 8000

VSA Capital Limited (AQSE Corporate Adviser)

Tel: +44(0)20 3005 5000

Andrew Raca

MHP Group (Financial PR Adviser)

Tel: +44 (0)20 3128 8000

Eleni Menikou

Aquis@mhpgroup.com

Finn Taylor

 

 

 Notes to editors:

About Aquis Exchange PLC

Aquis Exchange PLC ("Aquis") is Europe's challenger exchange, creating better markets for a modern economy. Aquis has market-leading technology and innovative rules for trading, and offer primary listings and secondary trading of equities, along with global licensing of proprietary technology.

Aquis consists of four divisions:

Aquis Markets operates lit and dark order books, covering 16 European markets. For its lit books, Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Technologies is the software and technology division of Aquis. It focuses on building better markets via the creation and licensing of cutting-edge, cost-effective exchange infrastructure technology and services, including matching engine and trade surveillance solutions.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex'; the Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Data generates revenue from the sale of data derived from Aquis Markets and Aquis Stock Exchange to non-Member market participants.

Aquis is authorised and regulated by the UK Financial Conduct Authority and France's Autorité de contrôle prudentiel et de résolution and L'Autorité des marchés financiers to operate Multilateral Trading Facility businesses in the UK & Switzerland markets and in EU27 markets respectively. Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the AIM Market (AIM) of the LSE. For more information, please go to www.aquis.eu.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSFLFVLRLISFIE
Date   Source Headline
26th Feb 20247:00 amRNSAquis launches conditional order functionality
23rd Feb 20247:00 amRNSNotice of Results and Investor Presentation
25th Jan 20247:00 amRNSTrading Update and Notice of Results
23rd Jan 20243:15 pmRNSExercise of Share Options and Total Voting Rights
21st Dec 20231:15 pmRNSDirector/PDMR Notification
29th Nov 20237:00 amRNSAQSE becomes first cloud-based RIE
24th Nov 202312:00 pmRNSDirector/PDMR Notification
2nd Nov 20237:00 amRNSHolding(s) in Company
31st Oct 202311:55 amRNSBoard Change
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 202312:39 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInterim Results
12th Sep 20237:00 amRNSAquis Markets - Change to Proprietary Trading Rule
7th Sep 20237:00 amRNSNotice of Results and Investor Presentation
6th Sep 20237:00 amRNSAppointment of Nominated Adviser and Joint Broker
7th Aug 20232:15 pmRNSAcquisition of Minority Interest
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAquis launches Dark to Lit Sweep
27th Apr 20237:00 amRNSDirector/PDMR Notification and Issue of Options
25th Apr 20232:18 pmRNSResult of AGM
14th Apr 20237:00 amRNSPublication of Annual Report & Notice of AGM
6th Apr 20231:05 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 202310:55 amRNSDirector/PDMR Shareholding
3rd Apr 20237:01 amRNSDirector/PDMR Shareholdings
3rd Apr 20237:00 amRNSAquis Launches The World’s First 24x7 Exchange
30th Mar 20237:00 amRNSFinal Results
22nd Feb 20237:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSTrading Update and Notice of Results
5th Jan 20237:00 amRNSDirectorate Change
12th Dec 20227:00 amRNSIG Expands UK Trading Offering With AQSE Stocks
24th Nov 20229:13 amRNSDirector/PDMR Notification
23rd Nov 20224:09 pmRNSDirector/PDMR Notification
2nd Nov 20227:00 amRNSNotice of Capital Markets Day
27th Sep 20227:00 amRNSNotice of Capital Markets Day
22nd Sep 20227:00 amRNSInterim Results
5th Sep 202212:00 pmRNSLaunch of new EU dark pool, Aquis Matching Pool
23rd Aug 20227:00 amRNSNotice of Results
6th Jul 202212:00 pmRNSAPEX stocks now trading on Hargreaves Lansdown
30th Jun 202212:49 pmRNSDirector/PDMR Notification and Issue of Options
23rd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:30 pmRNSExercise of Share Options and Total Voting Rights
26th May 20227:00 amRNSChange of registered address
29th Apr 20221:57 pmRNSDirector/PDMR Notification and Issue of Options
26th Apr 20223:05 pmRNSBoard Appointments
26th Apr 20222:59 pmRNSResult of AGM
4th Apr 20228:18 amRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.